Discover Tenders by Drugs Cancer Oncology Sector

Find the most relevant tenders for Drugs Cancer Oncology. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Drugs Cancer Oncology tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Drugs Cancer Oncology tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Estradiol G03Ca03 As Part Of A So Called Open House Model

Deadline: 30 Apr 2026

Germany

Ref. No.: 5719391

EMD:Ref Document

Bid Value: Ref Document

197 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Tocilizumab

Deadline: 11 May 2026

Germany

Ref. No.: 5718497

EMD:Ref Document

Bid Value: Ref Document

208 Days Left

Conclusion Not Excluding Drug Discount Agreement According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Budesonide Atc Code According To Who A07Ea06

Deadline: 30 Apr 2026

Germany

Ref. No.: 5718312

EMD:Ref Document

Bid Value: Ref Document

197 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Para 8 Sgb V For The Active Ingredient Rituximab

Deadline: 11 May 2026

Germany

Ref. No.: 5716614

EMD:Ref Document

Bid Value: Ref Document

208 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Cariprazine N05Ax15 As Part Of A So Called Open House Model

Deadline: 30 Apr 2026

Germany

Ref. No.: 5714435

EMD:Ref Document

Bid Value: Ref Document

197 Days Left

Open House Drug Discount Agreements Abatacept Atc Code L04Aa24

Deadline: 05 May 2026

Germany

Ref. No.: 5701703

EMD:Ref Document

Bid Value: Ref Document

202 Days Left

Open House Drug Discount Agreements Triptorelin Atc Code L02Ae04

Deadline: 05 May 2026

Germany

Ref. No.: 5701355

EMD:Ref Document

Bid Value: Ref Document

202 Days Left

Open House Drug Discount Agreements Nitisinone Atc Code A16Ax04

Deadline: 05 May 2026

Germany

Ref. No.: 5701197

EMD:Ref Document

Bid Value: Ref Document

202 Days Left

Open House Drug Discount Contracts Lanthanum Iii Carbonate Atc Code V03Ae03

Deadline: 05 May 2026

Germany

Ref. No.: 5701138

EMD:Ref Document

Bid Value: Ref Document

202 Days Left

Open House Drug Discount Contracts Fondaparinux Atc Code B01Ax05

Deadline: 05 May 2026

Germany

Ref. No.: 5701089

EMD:Ref Document

Bid Value: Ref Document

202 Days Left

Open House Drug Discount Agreements Botulinum Toxin Type A Finished Drug Name Dysport R Dysline R Atc Code M03Ax21

Deadline: 05 May 2026

Germany

Ref. No.: 5700891

EMD:Ref Document

Bid Value: Ref Document

202 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For Medicines With The Active Ingredient Buserelin Atc Code L02Ae01

Deadline: 27 Apr 2026

Germany

Ref. No.: 5700076

EMD:Ref Document

Bid Value: Ref Document

194 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Piribedil Atc N04Bc08 Obo For The Period July 1St 2024 June 30Th 2025 One Year Extension Option

Deadline: 05 May 2026

Germany

Ref. No.: 5687317

EMD:Ref Document

Bid Value: Ref Document

202 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Propranolol Exclusively Lse Atc C07Aa05 Obo For The Period July 1St 2024 June 30Th 2026

Deadline: 05 May 2026

Germany

Ref. No.: 5685615

EMD:Ref Document

Bid Value: Ref Document

202 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Etravirine Atc J05Ag04 Obo For The Period July 1St 2024 June 30Th 2026

Deadline: 05 May 2026

Germany

Ref. No.: 5683412

EMD:Ref Document

Bid Value: Ref Document

202 Days Left

Showing 48301 to 48315 of 48432 results

‹
1
2
...
3218
3219
3220
3221
3222
3223
3224
...
3228
3229
›

Discover Tenders by Drugs Cancer Oncology Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Drugs Cancer Oncology Sector

Filter Your Search

FREE Trial plan for all new users!